ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Benaroya Research Institute at Virginia Mason at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

Benaroya Research Institute at Virginia Mason brings 2 presentations to ACR Convergence 2026 in Orlando. Its program centres on T-cell biology, from engineering T cells for antigen-specific therapy to how T cells and fibroblasts interact in scleroderma skin.

OrganizationACR Convergence 2026 Attendance
Universities and research institutes
A biomedical research institute focused on immune-mediated diseases.
Talk
Tue Nov 10
9:00am–9:30am
Part of Beyond CD19: The Next Frontier in Engineered T-Cell Targets
Advancing Antigen Specific Therapy Through T Cell Engineering
W204
Treatment safety
Talk
Tue Nov 10
2:50pm–3:10pm
Part of NIAID FOCUS: Immune Control of Fibroblasts in Scleroderma
T Cell-Fibroblast Crosstalk and Dermal Fibroblast Dysfunction in Scleroderma
W204
Systemic sclerosis

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Benaroya Research Institute at Virginia Mason

Tell us what you sell and we’ll find the people at Benaroya Research Institute at Virginia Mason most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction